Enzon Pharmaceuticals Inc
(ENZN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2005 | 06-2004 | 06-2003 | 06-2002 | 06-2001 | |
| Sales | 166,250 | 169,571 | 146,406 | 75,805 | 31,588 |
| Cost of Goods | 46,023 | 46,986 | 28,521 | 6,078 | 3,864 |
| Gross Profit | 120,227 | 122,585 | 117,885 | 69,727 | 27,724 |
| Operating Expenses | 109,675 | 116,529 | 88,509 | 35,192 | 25,712 |
| Operating Income | 10,575 | 7,042 | 29,897 | 34,613 | 2,876 |
| Interest Expense | 19,829 | 19,829 | 19,828 | 19,829 | 275 |
| Other Income | -2,408 | 20,172 | 35,880 | 21,899 | 8,412 |
| Pre-tax Income | -11,662 | 7,385 | 45,949 | 36,683 | 11,013 |
| Income Tax | 77,944 | 3,177 | 223 | -9,123 | -512 |
| Net Income Continuous | -89,606 | 4,208 | 45,726 | 45,806 | 11,525 |
| Net Income | $-89,606 | $4,208 | $45,726 | $45,806 | $11,525 |
| EPS Basic Total Ops | -2.06 | 0.10 | 1.06 | 1.07 | 0.28 |
| EPS Basic Continuous Ops | -2.06 | 0.10 | 1.06 | 1.07 | 0.28 |
| EPS Diluted Total Ops | -2.06 | 0.10 | 1.05 | 1.04 | 0.26 |
| EPS Diluted Continuous Ops | -2.06 | 0.10 | 1.05 | 1.04 | 0.26 |
| EBITDA(a) | $37,640 | $31,882 | $43,729 | $34,734 | $2,632 |